Nanoparticles Flashcards
RNA interference
siRNA
MiRNA
SiRNA
Therapeutic agent
Endonucleolytic cleavage
One mRNA target
Fully complementary
MiRNA
Partially complimentary
Targets 3’ untranslated region
Translational repression
Degradation of MRNA
Endonucleolytic cleavage
Therapeutic agent
Drug delivery
Multiple targets
SaRNA
Self-amplifying RNA
CRNA
Can also be used as a bio marker
Mechanism of action of mRNA vaccines
Inject mRNA
MRNA interacts with dendritic cells
Dendritic cells produce antigens
Dendritic cells interact with T-cells
Cell destruction
Biological barriers to mRNA therapeutics
Protein optimization
Nuclease degradation
Inflammatory response
Limited endothelial extravasation
Mononuclear phagocytosis and RES entrapment
Intratumoral pressure
Negatively charged lipid belayer of cell membrane
Endosomal escape
Degradation by endonucleases
Modified chemistry that can escape endonucleases
Negatively charged lipid belayer of cell membrane
Formulate into nanoparticle DDS
MRNA nanotechnology closes
Catatonic lipid lipoplexes
Ionizable lipid nanoparticles
Polymeric carriers
Peptide carriers
Alternative vehicles
Cationic lipoplexes
Using positively charged lipoplexes to cross the negatively charged cell membrane
DOTMA
DOTAP
DOGS
Ionizable lipid nanoparticles
Multiple degree of inputs
Deals with toxicity issues in different pHs
Formulated with PEG conjugated lipid and a helper lipid like DOPE and DOPC
Polymer nanoparticles
Most have a primary amine at hat is complexed with the RNA backbone
PEI, PEG, PBAE, CART
Toxic when positively charged
Delivery vehicle modifications
PKa: determines their endosomal escape capacity
Chain length and linger rigidity affect translation (C12-C14 is optimal)
Double bond enhance sphere formation (e.g. linoleyl chains)
PEG length
Targeting agents: liver targeting ligands (ASPGR, ApoE) and dendritic cell targeting ligands (mannose, dectins, langerins)
Effect of route of administration
Most mRNA doses are localized in the liver with any route of admin
IV injection leads to accumulation in liver and lymph nodes
Wide distribution of systemic admin can leaf to antigen specific T cell immune response
Route of admin affects the distribution and efficacy of mRNA therapy